Tampere, Finland-based Bioretec said its acquisition is optimized for the production of magnesium-based implants. This especially includes the first product from the RemeOs family, the RemeOs screw. Bioretec’s RemeOs screw received FDA approval in March.
According to the company, the screw is the first and only bioresorbable metal implant approved by the FDA. The product’s range and indication align with a clinical trial conducted in the ankle, Bioretec says. Its bioresorbable metals combine surgical techniques from traditional metal implants with the benefits of last-generation bioresorbable polymer implants. These make implant removal operations redundant, according to Bioretec.
Bioretec designed its products to enhance bone growth and accelerate fracture healing after orthope…